Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease.

Citation data:

Neurobiology of aging, ISSN: 1558-1497, Vol: 59, Page: 107-120

Publication Year:
2017
Usage 77
Abstract Views 68
Link-outs 9
Captures 49
Readers 49
Mentions 25
News Mentions 19
Blog Mentions 6
Social Media 152
Tweets 80
Shares, Likes & Comments 72
Citations 6
Citation Indexes 6
PMID:
28888720
DOI:
10.1016/j.neurobiolaging.2017.07.006
Author(s):
Edler, Melissa K; Sherwood, Chet C; Meindl, Richard S; Hopkins, William D; Ely, John J; Erwin, Joseph M; Mufson, Elliott J; Hof, Patrick R; Raghanti, Mary Ann
Publisher(s):
Elsevier BV
Tags:
Neuroscience; Biochemistry, Genetics and Molecular Biology; Medicine
Most Recent Tweet View All Tweets
Most Recent Blog Mention
Most Recent News Mention
article description
Alzheimer's disease (AD) is a uniquely human brain disorder characterized by the accumulation of amyloid-beta protein (Aβ) into extracellular plaques, neurofibrillary tangles (NFT) made from intracellular, abnormally phosphorylated tau, and selective neuronal loss. We analyzed a large group of aged chimpanzees (n = 20, age 37-62 years) for evidence of Aβ and tau lesions in brain regions affected by AD in humans. Aβ was observed in plaques and blood vessels, and tau lesions were found in the form of pretangles, NFT, and tau-immunoreactive neuritic clusters. Aβ deposition was higher in vessels than in plaques and correlated with increases in tau lesions, suggesting that amyloid build-up in the brain's microvasculature precedes plaque formation in chimpanzees. Age was correlated to greater volumes of Aβ plaques and vessels. Tangle pathology was observed in individuals that exhibited plaques and moderate or severe cerebral amyloid angiopathy, a condition in which amyloid accumulates in the brain's vasculature. Amyloid and tau pathology in aged chimpanzees suggests these AD lesions are not specific to the human brain.